For research use only. Not for therapeutic Use.
Ampreloxetine（Cat No.:I009729）is an investigational selective norepinephrine reuptake inhibitor (NRI) being developed for the treatment of major depressive disorder (MDD) and attention-deficit hyperactivity disorder (ADHD). By increasing the levels of norepinephrine in the brain, Ampreloxetine aims to improve mood, attention, and cognitive function in individuals with these conditions. Preclinical and early clinical studies suggest it may offer benefits over traditional antidepressants by targeting specific neurotransmitter pathways. Ongoing clinical trials are evaluating its safety, efficacy, and potential as a new therapeutic option for patients with MDD, ADHD, and other related disorders.
| CAS Number | 1227056-84-9 |
| Synonyms | 4-[2-[(2,4,6-trifluorophenoxy)methyl]phenyl]piperidine |
| Molecular Formula | C18H18F3NO |
| Purity | ≥95% |
| IUPAC Name | 4-[2-[(2,4,6-trifluorophenoxy)methyl]phenyl]piperidine |
| InChI | InChI=1S/C18H18F3NO/c19-14-9-16(20)18(17(21)10-14)23-11-13-3-1-2-4-15(13)12-5-7-22-8-6-12/h1-4,9-10,12,22H,5-8,11H2 |
| InChIKey | TZIALEBTHQWNAO-UHFFFAOYSA-N |
| SMILES | C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
